FLT3 and acute myeloid leukemia: Here, we examined the characteristics and outcome of R/R FLT3-mutated AML patients included in the Toulouse–Bordeaux DATAML registry, in order to evaluate the efficacy of standard treatments that appeared to have limited efficacy in the ADMIRAL study.